Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b.

Source:http://linkedlifedata.com/resource/pubmed/id/10526196

J. Neurol. Sci. 1999 Oct 15 168 2 131-6

Download in:

View as

General Info

PMID
10526196